Lobbying Filing Details

Total Spending

$50,000

Activities

1

Lobbyists

5

Gov't Entities

2

Filing Information
Filing UUID:
929431be-7e7a-4731-876a-179e2d1e4fcb
Type:
Q3 - 3rd Quarter - Report
Period:
2025 - 3rd Quarter (July 1 - Sep 30)
Date Posted:
October 20, 2025 at 6:44 PM
Income:
$50,000
Expenses:
$0
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: James "J.D." Derderian
Registrant
STANTON PARK GROUP

government affairs

Annapolis, Maryland
Client
BRAEBURN PHARMACEUTICALS, INC.

pharmaceutical company

New Jersey, United States of America
Lobbying Activities (1)
Activity 1
Health Issues

Reducing stigma and promoting treatment of opioid use disorder; raising awareness of the benefits of medication assisted therapy (MAT); ensuring patient access to MAT; FDA approval and exclusivity process; patient access to practitioner-administered therapies Reauthorization of the Support Act.

Lobbyists (5)
  • VALERIE HENRY
  • JAMES DERDERIAN
  • JOSEPH RACHINSKY JR
  • MR. BRYAN WILLIAM WELLS
  • AISLING MCDONOUGH
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 9, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.